More articles about: All Research Topics
Health Lab
Removal of ventilator breathing tube is delayed for some patients, posing health risks
A study by Michigan Medicine determined how many patients who pass spontaneous breathing trials were extubated within six hours and what factors were associated with staying connected to a ventilator.
Health Lab
Study sheds light on why some prostate tumors are resistant to treatment
A new study from University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.
Health Lab
Study reveals mechanisms behind common mutation and prostate cancer
A study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate cancer—drive tumor initiation formation and therapeutic resistance.
Health Lab
Research links iron-mediated cell death and inflammatory bowel disease
New basic science insights into programmed cell death could offer relief for inflammatory bowel disease. The University of Michigan study reveals a connection between lipid reactive oxygen species, iron-mediated cell death and IBD.
News Release
From the Diag to the world: 175 years of U-M medical history
An interactive map and article that trace the history of Michigan Medicine
Health Lab
Older adults vary widely in preparing to “age in place”
Aging in place, or staying in your own home as you grow older, is key goal for many older adults, but a poll shows wide variation in what people over 65 are doing to prepare.
Health Lab
Affordable Care Act preventive services mandate key to transforming hepatitis C treatment
In an article researchers describe two potential futures: one in which 90% of hepatitis C cases in the United States are cured within five years and another in which the status quo of insufficient screening rates worsen in the absence of the ACA coverage mandate.
Health Lab
First-of-its-kind therapeutic device saves child in septic shock with multiorgan failure
The selective cytopheretic device, created by scientists and doctors at Michigan Medicine, is a first-in-class autologous immune cell directed therapy and successfully treated a young patient in septic shock and multiorgan failure.
Health Lab
Clinically deployed AI guidance for preventing C. difficile spread
AI guidance for clinicians aimed at reducing the spread of C.diff was deployed for the first time in a hospital setting, according to a University of Michigan-led study.
Health Lab
Avoiding recovery delays with hospitalized pancreatitis
Acute pancreatitis is among the most common gastrointestinal conditions requiring inpatient hospital care in the United States. Balancing the signaling of the interleukin-22 protein and interleukin-22 binding protein is crucial to recovery from acute and chronic pancreatitis.
Health Lab
Simple muscle ultrasound may detect early prediabetes
A simple ultrasound of a patient’s thigh or shoulder muscle may detect insulin resistance before it progresses to type 2 diabetes or even prediabetes. In a study, Michigan Medicine researchers performed muscle ultrasounds on 25 patients who were also evaluated for insulin resistance.
Health Lab
Living near harmful algal blooms reduces life expectancy with ALS
Living close to cyanobacterial harmful algal blooms — which are present nationwide but are more common in coastal and Great Lake states — heightens the rate of dying from amyotrophic lateral sclerosis, or ALS, a study suggests.
Health Lab
Many parents struggle letting teens have independence on family vacations
One in five parents say they’ve never allowed their teen to be away from them during a trip.
Health Lab
Study defines key driver of aggressive ovarian cancer
A study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments.
Health Lab
Patients are opting in for 10 years of breast cancer treatment
As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study sheds light on whether patients are opting for it.